Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Running it alongside a concurrent multi-peptide protocol would create a scheduling overlap that conflicts with its design as a standalone reset
This material is for research only and is not intended for human consumption or clinical applications
Approval status: Unlike most peptides on this site, tesamorelin is FDA-approved (brand Egrifta / Egrifta SV ) but only for one specific indication: reducing excess abdominal fat in HIV-associated lipodystrophy
Are you a Health Care Professional
Results consistently show major reductions in inflammatory markers (IL-6, TNF-alpha, CRP), less pain behavior in animal models, reduced swelling, and better function without the side effects of traditional anti-inflammatory drugs
,
US$ 28.88
US$ 20.12
US$ 23.65
US$ 29.69
US$ 20.62
US$ 23.01
